Evolent Health, Inc.
Evolent Health, Inc. (NYSE: EVH) is trading at $3.96, about ₹384 at today's USD/INR rate, as of 8 Oct 2026, 4:00 PM ET, down 4.35% today. Indian residents can buy Evolent Health from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$3.84
Today's high
$4.13
52 week low
$2.10
52 week high
$8.33
EVH opened at $4.10, closed previously at $4.14, and has traded between $2.10 and $8.33 over the past 52 weeks.
About
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Key statistics
Avg. volume
2.37M
Market cap
$445.43M
P/E Ratio
-0.88
Price-to-sales ratio
0.21
Enterprise value
$1.29B
Free cash flow yield
1.04%
Debt-to-equity ratio
2.53
Return on equity
-128.74%
ROIC
-0.29%
Beta
0.84
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$1.88B
Earnings per share
-$5.07
Free cash flow
$4.75M
Net profit margin
-24.08%
Gross margin
12.92%
EBITDA
-$361.31M
Revenue growth
-26.56%
Similar securities
This is not an investment recommendation
How to buy Evolent Health from India
Indian residents can buy Evolent Health shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Evolent Health from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Evolent Health and place an order
Find Evolent Health by name or by its ticker, EVH, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Evolent Health trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Evolent Health position in USD and INR. Evolent Health pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Trading and taxes when buying Evolent Health from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneEvolent Health does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
FAQs
Can Indian residents buy Evolent Health stock?
Yes. Evolent Health (EVH) has been listed on the New York Stock Exchange since 2015, in the Medical - Healthcare Information Services industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Evolent Health share cost in rupees?
One Evolent Health share is $3.96 — about ₹384 at a USD/INR rate of 96.88 on 8 Oct 2026. Both the Evolent Health price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Evolent Health from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Evolent Health?
Yes. One Evolent Health share is $3.96, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Evolent Health.
How are gains on Evolent Health shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Evolent Health price. Paasa issues a capital-gains statement for your return.
Does Evolent Health pay a dividend?
No. Evolent Health does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Evolent Health from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Evolent Health shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Evolent Health shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Evolent Health holding, its cost and its closing value.
How do I sell Evolent Health and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.